Treatment With Immunoglobulin And Adverse Events In PID (Primary Immunodeficiency)

被引：0
|
作者：
Puget, Sophie [1 ]
Darnige, Luc [2 ]
机构：
[1] LFB Biomed, Int Sci Affairs Unit, Lublin, Poland
[2] Hosp Europeen Georges Pompidou, AP HP Paris, Haematol Unit, Paris, France
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2015年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P43
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [41] Treatment modalities and clinical efficacy of immunoglobulin G replacement therapies in primary immunodeficiency
    Webster, ADB
    INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 21 - 28
  • [42] Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in Patients With Primary Immunodeficiency Diseases: Interim Analysis of Adverse Events in a Global Post-Authorization Safety Study
    Rubinstein, Arye
    Bridges, Tracy A.
    Wedner, H. James
    McNeil, Donald
    Wasserman, Richard L.
    Tachdjian, Raffi
    Stryk, Steven V.
    Tarpay, Martha M.
    Fielhauer, Katharina
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB117 - AB117
  • [43] Advanced Cell-Based Therapies for the Treatment of Primary Immunodeficiency (Cell-PID)
    不详
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2014, 25 (02) : 54 - 56
  • [44] THE BENEFIT OF IG TREATMENT AND IMPACT OF PRIMARY IMMUNODEFICIENCY (PID) ON PATIENTS' QUALITY OF LIFE (QOL)
    Espanol, T.
    Prevot, J.
    Drabwell, J.
    Olding, L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 173 - 173
  • [45] Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
    Jolles, Stephen
    IMMUNOTARGETS AND THERAPY, 2013, 2 : 125 - 133
  • [46] The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
    Azizi, Gholamreza
    Abolhassani, Hassan
    Asgardoon, Mohammad Hosein
    Rahnavard, Javad
    Dizaji, Majid Zaki
    Yazdani, Reza
    Mohammadi, Javad
    Aghamohammadi, Asghar
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2016, 16 (02) : 80 - 88
  • [47] Hyper Immunoglobulin E in Primary Immunodeficiency Disorders
    Ben Khaled, M.
    Thraya, S.
    Ouederni, M.
    Bouzidi, L.
    Dhouib, N.
    Haoua, A.
    Hassouna, R.
    Mellouli, F.
    Bejaoui, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S237 - S237
  • [48] Intravenous immunoglobulin treatment of immunodeficiency disorders
    Schwartz, SA
    PEDIATRIC CLINICS OF NORTH AMERICA, 2000, 47 (06) : 1355 - +
  • [49] Intravenous Immunoglobulin Treatment of Immunodeficiency Preface
    Roifman, Chaim M.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2008, 28 (04) : XV - XVI
  • [50] Intravenous human immunoglobulin infusion adverse effects in patients with immunodeficiency
    Cortez Aliaga, G. L.
    Brolio, A.
    Gomes, L.
    Anagusko, C. L. Y.
    Grecco, O.
    Marinho, A. K. B.
    Kalil, J.
    Kokron, C. M.
    Barros, M. T.
    ALLERGY, 2019, 74 : 349 - 349
12345